Try our Advanced Search for more refined results
Corporate
-
February 05, 2026
Cooley Adds Ex-Kirkland Corporate Real Estate Leader In NY
Cooley LLP announced it has hired the former leader of Kirkland & Ellis LLP's corporate real estate team.
-
February 05, 2026
Alston & Bird Hires Ex-Baker McKenzie Tech, Privacy Pro
Alston & Bird LLP has added a technology and privacy specialist previously with Baker McKenzie as a partner in its Silicon Valley office, the firm announced Thursday.
-
February 04, 2026
Albright Axes Texas' Anti-ESG Law As Unconstitutional
Texas' law restricting state investments with financial firms and businesses that want to reduce their reliance on fossil fuels is both "overbroad and unconstitutionally vague," a federal judge has ruled, handing a sustainability-focused business group a summary judgment victory.
-
February 04, 2026
Medtronic Owes $381M For Antitrust 'War Games,' Jury Told
An attorney for Applied Medical told a California federal jury Wednesday during closing arguments in an antitrust trial against Medtronic that internal documents from the medical device giant show it played illegal "war games" against his client and should pay up to $381 million.
-
February 04, 2026
Wash. AG Defends 'Constitutional' Anti-Spam Law In Ulta Suit
Washington's attorney general is defending the constitutionality of a state anti-spam law, denying arguments by beauty retailer Ulta that the statute is an undue burden on interstate commerce and runs afoul of federal law.
-
February 04, 2026
Class Attys In Del. Northwest Biotherapeutics Praise Deal
Delaware Chancery Court has lined up a March 16 settlement hearing for a four-year stockholder lawsuit alleging insiders of Northwest Biotherapeutics Inc. received $40 million in stock awards, with proposals including a call for the company to forfeit nearly 22.9 million stock options and it receiving $2.25 million.
-
February 04, 2026
'Extraordinary Circumstances': Elon Musk Faces USAID Depo
A Maryland federal judge on Wednesday said billionaire Elon Musk must testify in litigation filed by U.S. Agency for International Development employees claiming he illegally dismantled the foreign aid agency while head of the advisory organization known as the Department of Government Efficiency, saying "extraordinary circumstances justify the deposition."
-
February 04, 2026
Oracle Oversold AI Infrastructure Spending, Investor Says
An Oracle Corp. shareholder has accused the company in Delaware federal court of overly promising that its increased spending on artificial intelligence infrastructure would accelerate revenue growth despite concerns about its increasing contractual reliance on OpenAI, saying OpenAI itself is beholden to "AI tailwinds continuing and its models being a market leader."
-
February 04, 2026
SEC Cases May Rise After 'Unprecedented' 2025, Attys Say
Following an "unprecedented" year in which the U.S. Securities and Exchange Commission dismissed the bulk of its crypto docket and filed few new lawsuits, former SEC staff members said Wednesday that there are signs that enforcement actions could begin to ramp up this year.
-
February 04, 2026
Under Armour Wants 4th Circ. To Review $100M Coverage Cap
Under Armour asked the Fourth Circuit to review a recent ruling that capped its coverage for a securities class action, government investigations and derivative matters at $100 million, saying the panel overlooked the significance of an endorsement that essentially settled a dispute over when certain claims were made.
-
February 04, 2026
Loeb & Loeb To Guide SPAC's Merger With Packaging Co.
Loeb & Loeb LLP is advising a special purpose acquisition company on its proposed combination with Taiwan-based packaging solutions company Deluxe Technology Group, according to an announcement on Wednesday.
-
February 04, 2026
Chancery Asked For 120-Day Stay Of Virgin Galactic Suit
The Delaware Chancery Court has been asked to temporarily pause a stockholder derivative suit accusing Virgin Galactic founder Richard Branson and other leaders of the spaceflight company of concealing safety risks while selling stock, as related litigation over similar allegations moves toward possible settlement in federal court.
-
February 04, 2026
Drugmakers Say Hagens Berman Responsible For Costs
Drugmakers including GSK and Sanofi have told a Pennsylvania federal court that plaintiffs firm Hagens Berman Sobol Shapiro LLP should bear the costs for the special master tasked with sorting out long-running disputes in a since-dropped product liability suit.
-
February 04, 2026
Wachtel Missry Settles Liability In $26M Atty Malpractice Case
A dispute over who is liable for a former Wachtel Missry LLP partner's alleged exploitation of an elderly client has been settled on the eve of trial, while the Brooklyn federal judge declined to consider recusing himself despite "inadvertently" meeting with the firm's founding partner before the matter was fully put to rest.
-
February 04, 2026
Cooley, Ropes & Gray Transactional Attys Move To Latham
Latham & Watkins LLP announced Tuesday that it has hired two partners to help the firm meet evolving capital and growth demands — a Los Angeles-based emerging companies attorney from Cooley LLP and a New York-based capital markets attorney from Ropes & Gray LLP.
-
February 04, 2026
Stockholders Ask Del. Justices To Revive Bylaw Suits
Stockholders challenging advance notice bylaws at AES Corp. and Owens Corning urged the Delaware Supreme Court on Wednesday to revive their dismissed suits, saying boards should face fiduciary duty scrutiny the moment they adopt allegedly entrenching bylaws, not only after a proxy contest is triggered.
-
February 04, 2026
Ex-Pentagon GC Joins Bradley Arant's National Security Team
Bradley Arant Boult Cummings LLP has hired the former legal adviser to the National Security Council, who is joining the team in Nashville, Tennessee, and Washington, D.C., to work with the firm's Government Enforcement & Investigations and Defense & National Security teams, the firm announced Tuesday.
-
February 04, 2026
Express Scripts Makes 'Fundamental Changes' In FTC Deal
Express Scripts on Wednesday agreed to what the Federal Trade Commission called a "landmark settlement" promising major changes to its drug formulary practices, allowing the company to duck out of a case accusing all three of the country's largest pharmacy benefit managers of inflating insulin prices through rebate schemes.
-
February 03, 2026
XAI Fights Uphill To Keep Alive OpenAI IP Theft Suit
Elon Musk's xAI urged a California federal judge Tuesday to change her tentative decision to toss its suit accusing OpenAI of poaching its workers to steal trade secrets, arguing that when considered together, the "whole gestalt" of xAI's allegations against individual employees is enough to state viable claims against OpenAI.
-
February 03, 2026
Calif. Privacy Agency Taps Meta Alum To Head New Audits Unit
The California Privacy Protection Agency on Tuesday announced the creation of a new Audits Division to assess companies' compliance with the state's consumer data privacy framework and named the most recent director of public policy at social media giant Meta Platforms Inc. to lead the unit.
-
February 03, 2026
ImmunityBio Stockholder Targets Soon-Shiong In Chancery
The Delaware Chancery Court on Tuesday heard arguments over whether biotech billionaire Patrick Soon-Shiong and ImmunityBio Inc.'s board breached their fiduciary duties by approving insider financing that allegedly allowed him to secure equity at deeply discounted prices as the company neared regulatory approval for its lead cancer drug.
-
February 03, 2026
Wachtell Lipton, Davis Polk Steer $12B Santander Deal
Wachtell Lipton Rosen & Katz and Davis Polk & Wardwell LLP are guiding Banco Santander SA's $12.3 billion cash-and-stock acquisition of Webster Financial Corp., according to an announcement made Tuesday.
-
February 03, 2026
Uber Should Pay $144M For Sex Assault By Driver, Jury Told
Uber should pay more than $144 million in compensatory and punitive damages for choosing "profit over safety," leading to the rape of a 19-year-old woman by a rideshare driver, her lawyer told an Arizona federal jury at the close of a landmark bellwether trial on Tuesday.
-
February 03, 2026
Medtronic's Bundling Isn't Anticompetitive, Prof Tells Jury
A University of Chicago economics professor testified Tuesday in a California federal trial over antitrust claims against Medtronic, saying its practice of bundling its advanced bipolar devices for sales with other products isn't anticompetitive but is actually a very common American practice used by the likes of McDonald's and Costco.
-
February 03, 2026
SEC Tosses Biden-Era Case Against Wyoming Crypto Co.
The U.S. Securities and Exchange Commission has walked away from an attempt to block the issuance of a pair of digital tokens offered by a Wyoming-based company, saying that changes in federal policy toward the cryptocurrency industry necessitated an end to the administrative proceedings.
Expert Analysis
-
Examining Privilege In Dual-Purpose Workplace Investigations
The Sixth Circuit's recent holding in FirstEnergy's bribery probe ruling that attorney-client privilege applied to a dual-purpose workplace investigation because its primary purpose was obtaining legal advice highlights the uncertainty companies face as federal circuit courts remain split on the appropriate test, say attorneys at Proskauer.
-
Hot Topics For Family Offices In 2026
For family offices, the throughline of 2026 is disciplined readiness, as navigating impact from the One Big Beautiful Bill Act and platform maturation will be necessary to preserve flexibility and enhance client outcomes, say attorneys at Morgan Lewis.
-
Opinion
The Case For Emulating, Not Dividing, The Ninth Circuit
Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.
-
Autonomous AI Attacks Demarcate Shift In Risk Landscape
Anthropic and OpenAI recently disclosed cyberattacks where an artificial intelligence agent was the primary attacker, illustrating immediate implications for corporate governance, contracting and security programs as companies integrate AI with their business systems, say Rahul Mukhi and Melissa Faragasso at Cleary and Brian Lichter at Stroz Friedberg.
-
2025's Defining AI Securities Litigation
Three securities litigation decisions from 2025 — involving General Motors, GitLab and Tesla — offer a preview of how courts will assess artificial intelligence-related disclosures, as themes such as heightened regulatory scrutiny and risk surrounding technical claims are already taking shape for the coming year, say attorneys at Cooley.
-
How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases
Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.
-
Targeted Action, Rule Tweaks Reflect 2025 AML Priority Shifts
Though 2025’s anti-money-laundering landscape was characterized not by volume of penalties but by the strategic recalibration of how illicit finance risk is handled, a series of targeted enforcement actions signaled that regulators aren't easing off the accelerator, even as they refine the rules of the road, say attorneys at MoFo.
-
Series
Mass. Banking Brief: All The Notable Legal Updates In Q4
Among the most significant developments on the banking regulation front in Massachusetts last quarter, Attorney General Andrea Joy Campbell announced her bid for reelection, and the state Division of Banks continued its fintech focus by finalizing rules implementing a new money transmitter law, say attorneys at Nutter.
-
Series
Muay Thai Makes Me A Better Lawyer
Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.
-
Series
Law School's Missed Lessons: Intentional Career-Building
A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.
-
Series
A Day In The In-House Life: Chime GC Talks Pathfinding
On a recent Tuesday in the office, Chime's general counsel Adam Frankel shares his typical work day, tackling everything from strategically guiding product launches and testing AI tools to mastering the perfect latte and making time for extracurricular interests.
-
How Shareholder Activism Fared In 2025
2025 was a turbulent yet transformative year in shareholder activism, and there are several key takeaways to help companies prepare for a 2026 that is shaping up to be even more lively, including increased focus on retail investors and the use of social media as a tool, say attorneys at Sidley.
-
Reviewing 2025's Artificial Intelligence Disputes Over IP
2025 brought the first major fair use rulings involving generative artificial intelligence, and in 2026 courts will weigh in on more discovery disputes, renewed motions to dismiss, class certification challenges and fair use defenses that could shape the course of future AI litigation, say attorneys at Debevoise.
-
Expect A New Normal In Commercial Real Estate This Year
Even amid office vacancies and a wave of loan maturities, the commercial real estate market isn't as volatile as one might expect heading into 2026, but market stress is still uniquely intersecting with broader business challenges, creating new opportunities for corporate counsel and other practitioners beyond real estate, says Mark Bell at Stinson.
-
Key Trends In Healthcare Antitrust In 2025
The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.